Antitumor activity of Tigerinin-1: Necroptosis mediates toxicity in A549 cells.


Journal

Biochimica et biophysica acta. General subjects
ISSN: 1872-8006
Titre abrégé: Biochim Biophys Acta Gen Subj
Pays: Netherlands
ID NLM: 101731726

Informations de publication

Date de publication:
09 2022
Historique:
received: 08 04 2022
revised: 20 05 2022
accepted: 24 05 2022
pubmed: 1 6 2022
medline: 22 6 2022
entrez: 31 5 2022
Statut: ppublish

Résumé

Tigerinins are antimicrobial peptides (AMPs) derived from the skin secretions of the Indian bullfrog Hoplobatrachus tigerinus. Tigerinin-1 (FCTMIPIPRCY-Am) peptide was synthesized by solid-phase Fmoc chemistry and investigated its antitumor activities. Tigerinin-1 was cytotoxic to human cancer cells. It causes necrosis by damaging the cell membrane and loss of lysosome integrity. Tigerinin-1triggers the expression of necroptosis pathway proteins. It generates reactive oxygen species (ROS) and induces oxidative stress-mediated genotoxicity. Tigerinin-1 inhibits cancer cell proliferation, reduces neovascularization, and down-regulates the vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor 2 (VEGFR2), and fibroblast growth factor (FGF) genes. Tigerinin-1 exhibited its potent antitumor properties in this study. Tigerinin-1 can be beneficial for developing novel therapeutics for cancer.

Sections du résumé

BACKGROUND
Tigerinins are antimicrobial peptides (AMPs) derived from the skin secretions of the Indian bullfrog Hoplobatrachus tigerinus.
METHODS
Tigerinin-1 (FCTMIPIPRCY-Am) peptide was synthesized by solid-phase Fmoc chemistry and investigated its antitumor activities.
RESULTS
Tigerinin-1 was cytotoxic to human cancer cells. It causes necrosis by damaging the cell membrane and loss of lysosome integrity. Tigerinin-1triggers the expression of necroptosis pathway proteins. It generates reactive oxygen species (ROS) and induces oxidative stress-mediated genotoxicity. Tigerinin-1 inhibits cancer cell proliferation, reduces neovascularization, and down-regulates the vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor 2 (VEGFR2), and fibroblast growth factor (FGF) genes.
CONCLUSIONS
Tigerinin-1 exhibited its potent antitumor properties in this study.
GENERAL SIGNIFICANCE
Tigerinin-1 can be beneficial for developing novel therapeutics for cancer.

Identifiants

pubmed: 35636711
pii: S0304-4165(22)00100-3
doi: 10.1016/j.bbagen.2022.130182
pii:
doi:

Substances chimiques

Antimicrobial Cationic Peptides 0
Vascular Endothelial Growth Factor A 0
tigerinin 1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

130182

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Anet Antony (A)

Department of Zoology, School of Biological Sciences, Central University of Kerala, Tejaswini Hills, Periya 671 320, Kasaragod, India.

Shilpa Olakkaran (S)

Department of Zoology, School of Biological Sciences, Central University of Kerala, Tejaswini Hills, Periya 671 320, Kasaragod, India.

Anupama Kizhakke Purayil (AK)

Department of Zoology, School of Biological Sciences, Central University of Kerala, Tejaswini Hills, Periya 671 320, Kasaragod, India.

Shamasoddin Shekh (S)

Department of Chemistry, School of Chemical Sciences, Central University of Karnataka, Kalaburagi 585 367, Karnataka, India.

Konkallu Hanumae Gowd (KH)

Department of Chemistry, School of Chemical Sciences, Central University of Karnataka, Kalaburagi 585 367, Karnataka, India.

Hunasanahally Puttaswamygowda Gurushankara (HP)

Department of Zoology, School of Biological Sciences, Central University of Kerala, Tejaswini Hills, Periya 671 320, Kasaragod, India. Electronic address: gurushankara@cukerala.ac.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH